The drug is now approved for treating people with an LVEF of at least 40%, with or without chronic kidney disease.

Patients taking Kerendia saw significant reduction in cardiovascular death and hospitalization and urgent visits for heart ...

Scientists have discovered that four health habits — which include sleep quality and nicotine use — were the most important ...

The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.

After menopause, individuals with cardiovascular disease and weight gain may face a higher risk of breast cancer, recent ...

Sleep ended up being the biggest predictor of having a cardiovascular disease event and dying from any cause. The underlying ...

In addition to exercise and a balanced diet, supplements like omega-3 can boost cardiovascular health and reduce the risk of ...

Following priority review, the U.S. Food and Drug Administration approved Bayer's Kerendia (finerenone) for the treatment of ...

Wearables and telehealth are teaming up to transform chronic care. This connected model offers real-time data for proactive, ...

Micah Clayborne was diagnosed with Danon disease, a rare condition, after complaining of chest pains. He needed a heart ...

With India witnessing a quiet explosion in heart failure cases, many striking working-age adults, STAR Hospitals has launched ...

Finerenone gained FDA approval for heart failure treatment, showcasing significant benefits in reducing cardiovascular events ...